Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab added to methotrexate and intra-articular glucocorticoids in early rheumatoid arthritis
2011-006040-79Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- May 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Tocilizumab add-on arm with Placebo add-on arm (2 arms). Primary endpoint: DAS28 remission at month 16. Started May 2012; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-006040-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006040-79.